Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients. [electronic resource]
Producer: 20100520Description: 358-65 p. digitalISSN:- 1538-7755
- Adenocarcinoma -- classification
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Bevacizumab
- Biomarkers, Tumor -- analysis
- Carcinoma, Non-Small-Cell Lung -- classification
- Carcinoma, Squamous Cell -- classification
- Cetuximab
- Colorectal Neoplasms -- classification
- ErbB Receptors -- metabolism
- Erlotinib Hydrochloride
- Gefitinib
- Head and Neck Neoplasms -- classification
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- classification
- Mass Spectrometry
- Mutation
- Protein Kinase Inhibitors -- therapeutic use
- Proteomics
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins p21(ras)
- Quinazolines -- therapeutic use
- Signal Transduction -- physiology
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.